Literature DB >> 22654253

Acute Thrombosis of Left Portal Vein during Right Portal Vein Embolization Extended to Segment 4.

Colette M Shaw1, David C Madoff.   

Abstract

Portal vein thrombosis (PVT) is an uncommon, but potentially devastating complication of portal vein embolization (PVE). Its occurrence relates to both local and systemic risk factors. In the setting of PVE, precipitating factors include injury to the vessel wall and reduced portal flow. Contributory factors include portal hypertension, hypercoagulopathy, inflammatory processes, malignancy, pregnancy, oral contraceptive use, and asplenia. The goal of therapy is to prevent thrombus progression and lyse existing clot. Hepatectomy is impossible if adequate recanalization has not occurred and/or overt portal hypertension develops. The mechanisms for thrombus development, its diagnosis, management, and prognosis are discussed.

Entities:  

Keywords:  Portal vein embolization; liver hypertrophy; liver resection; thrombosis

Year:  2011        PMID: 22654253      PMCID: PMC3193332          DOI: 10.1055/s-0031-1280655

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  12 in total

1.  Catheter-directed thrombolysis with transjugular access in portal vein thrombosis secondary to pancreatitis.

Authors:  C Aytekin; F Boyvat; A Kurt; Z Yologlu; M Coskun
Journal:  Eur J Radiol       Date:  2001-08       Impact factor: 3.528

2.  Treatment of portal venous thrombosis with selective superior mesenteric artery infusion of recombinant tissue plasminogen activator.

Authors:  E A Henao; W Todd Bohannon; M B Silva
Journal:  J Vasc Surg       Date:  2003-12       Impact factor: 4.268

Review 3.  Portal vein thrombosis: etiology, diagnostic strategy, therapy and management.

Authors:  N Hidajat; H Stobbe; V Griesshaber; R J Schroder; R Felix
Journal:  Vasa       Date:  2005-05       Impact factor: 1.961

4.  Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils.

Authors:  David C Madoff; Eddie K Abdalla; Sanjay Gupta; Tsung-Teh Wu; Jeffrey S Morris; Alban Denys; Michael J Wallace; Frank A Morello; Kamran Ahrar; Ravi Murthy; Simon Lunagomez; Marshall E Hicks; Jean-Nicolas Vauthey
Journal:  J Vasc Interv Radiol       Date:  2005-02       Impact factor: 3.464

5.  Complications of percutaneous transhepatic portal vein embolization.

Authors:  Yoshihisa Kodama; Tadashi Shimizu; Hideho Endo; Noriyuki Miyamoto; Kazuo Miyasaka
Journal:  J Vasc Interv Radiol       Date:  2002-12       Impact factor: 3.464

Review 6.  Protein S deficiency.

Authors:  D Borgel; S Gandrille; M Aiach
Journal:  Thromb Haemost       Date:  1997-07       Impact factor: 5.249

7.  Portal vein thrombosis associated with active ulcerative colitis: percutaneous transhepatic recanalization.

Authors:  Y Miyazaki; Y Shinomura; S Kitamura; S Hiraoka; K Tomoda; R Nezu; W Kamiike; H Nakamura; Y Matsuzawa
Journal:  Am J Gastroenterol       Date:  1995-09       Impact factor: 10.864

8.  Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients.

Authors:  Donatella R Di Stefano; Thierry de Baere; Alban Denys; Antoine Hakime; Gilles Gorin; Michel Gillet; Jean Saric; Hervé Trillaud; Philippe Petit; Jean-Michel Bartoli; Dominique Elias; Jean-Robert Delpero
Journal:  Radiology       Date:  2004-12-10       Impact factor: 11.105

9.  Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report.

Authors:  M Makuuchi; B L Thai; K Takayasu; T Takayama; T Kosuge; P Gunvén; S Yamazaki; H Hasegawa; H Ozaki
Journal:  Surgery       Date:  1990-05       Impact factor: 3.982

10.  Portal and mesenteric vein thrombosis after portal vein embolization in a patient with protein S deficiency.

Authors:  Masayuki Ohkubo; Masato Nagino; Junichi Kamiya; Toshiyuki Arai; Hideki Nishio; Yuji Nimura
Journal:  J Hepatobiliary Pancreat Surg       Date:  2004
View more
  5 in total

1.  Inverting the ALPPS paradigm by minimizing first stage impact: the Mini-ALPPS technique.

Authors:  Eduardo de Santibañes; Fernando A Alvarez; Victoria Ardiles; Juan Pekolj; Martin de Santibañes
Journal:  Langenbecks Arch Surg       Date:  2016-04-15       Impact factor: 3.445

2.  Ethylene vinyl alcohol copolymer for occlusion of specific portal branches during preoperative portal vein embolisation with n-butyl-cyanoacrylate.

Authors:  Romain Breguet; Sana Boudabbous; Lawrence F Pupulim; Christoph D Becker; Laura Rubbia-Brandt; Christian Toso; Maxime Ronot; Sylvain Terraz
Journal:  Eur Radiol       Date:  2018-05-22       Impact factor: 5.315

Review 3.  Strategies to increase the resectability of hepatocellular carcinoma.

Authors:  Wong Hoi She; Kenneth Sh Chok
Journal:  World J Hepatol       Date:  2015-08-28

4.  Complications of Portal Vein Embolization: Evaluation on Cross-Sectional Imaging.

Authors:  Yoo Kyeong Yeom; Ji Hoon Shin
Journal:  Korean J Radiol       Date:  2015-08-21       Impact factor: 3.500

Review 5.  Portal Vein Embolization as an Oncosurgical Strategy Prior to Major Hepatic Resection: Anatomic, Surgical, and Technical Considerations.

Authors:  Sonia T Orcutt; Katsuhiro Kobayashi; Mark Sultenfuss; Brian S Hailey; Anthony Sparks; Bighnesh Satpathy; Daniel A Anaya
Journal:  Front Surg       Date:  2016-03-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.